B2i Digital to co-host June 24-25 life sciences investor forum

B2i Digital will host a two-day Life Sciences Virtual Investor Forum on June 24-25 with Virtual Investor Conferences and Zacks Small-Cap Research, giving investors access to company presentations across biotech, diagnostics, devices and digital health. The event is designed to pair live management access with independent research and one-on-one meetings. Why it matters: - The forum gives investors a concentrated look at public and private life sciences companies across biotechnology, diagnostics, medical devices and digital health. - The event pairs live presentations with one-on-one meeting requests, which can speed up investor-company interaction. - B2i Digital says the forum reaches a proprietary network of more than 1.7 million retail and institutional market participants. What happened: - B2i Digital invited investors to the Life Sciences Virtual Investor Forum, a Featured Conference, set for June 24-25, 2026. - Virtual Investor Conferences and Zacks Small-Cap Research are co-hosting the two-day event. - The forum is being promoted and distributed by B2i Digital as the official marketing partner. - Replays will be available on B2i Digital and OTC Markets YouTube channels. The details: - Each company gets 30 minutes for a live presentation and Q&A. - One-on-one meeting requests are available through the VIC site, with registration and company profiles available here . - More information about the forum is available here . - Zacks Small-Cap Research, a preferred provider in OTC Markets Group’s Research Marketplace, will supply independent company-sponsored research and related content. - The presenting lineup includes companies in clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science and AI-powered digital health. - Presenting companies were listed as of June 17, 2026 and are subject to change. Between the lines: - The format reflects a growing preference among small-cap and growth investors for direct access to management plus third-party research. - B2i Digital is using its conference and media network to drive both attendance and follow-up meetings, not just awareness. - The breadth of the roster suggests organizers are targeting investors who want exposure across multiple life sciences subsectors in one event. - David Shapiro, B2i Digital CEO, said investors want efficient, direct access to management teams and that pairing access with independent research makes the forum more valuable. What’s next: - The forum will run on Wednesday, June 24, and Thursday, June 25. - Investors can request one-on-one meetings before and during the event. - Presentations and Q&A sessions will roll out across both days, starting at 9:30 a.m. ET on June 24 and 9:30 a.m. ET on June 25. - The company lineup as of June 17 includes: - Day One: Protalix BioTherapeutics, MetaVia, CytoSorbents, PetVivo, Jaguar Health, Reviva Pharmaceuticals and 4DMedical. - Day Two: Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex Biotherapeutics, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma and NuFarm. - Additional company participation may change before the event. The bottom line: - B2i Digital is packaging a two-day life sciences investor forum around live management access, independent research and a broad cross-section of subsectors, aiming to turn online presentations into direct investor meetings.